These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18820279)

  • 1. Rosuvastatin protects against podocyte apoptosis in vitro.
    Cormack-Aboud FC; Brinkkoetter PT; Pippin JW; Shankland SJ; Durvasula RV
    Nephrol Dial Transplant; 2009 Feb; 24(2):404-12. PubMed ID: 18820279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis.
    Wada T; Pippin JW; Terada Y; Shankland SJ
    Kidney Int; 2005 Oct; 68(4):1618-29. PubMed ID: 16164639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
    Marshall CB; Krofft RD; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.
    Logar CM; Brinkkoetter PT; Krofft RD; Pippin JW; Shankland SJ
    Kidney Int; 2007 Aug; 72(4):489-98. PubMed ID: 17554257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins.
    Wada T; Pippin JW; Marshall CB; Griffin SV; Shankland SJ
    J Am Soc Nephrol; 2005 Sep; 16(9):2615-25. PubMed ID: 15987750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
    Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
    BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
    Xiao H; Shi W; Liu S; Wang W; Zhang B; Zhang Y; Xu L; Liang X; Liang Y
    Am J Nephrol; 2009; 30(1):34-43. PubMed ID: 19202327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo.
    Marshall CB; Pippin JW; Krofft RD; Shankland SJ
    Kidney Int; 2006 Dec; 70(11):1962-73. PubMed ID: 17035936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of bad in podocyte apoptosis induced by puromycin aminonucleoside.
    Yu SY; Qi R
    Transplant Proc; 2013 Mar; 45(2):569-73. PubMed ID: 23498794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.
    Whaley-Connell A; Habibi J; Nistala R; Cooper SA; Karuparthi PR; Hayden MR; Rehmer N; DeMarco VG; Andresen BT; Wei Y; Ferrario C; Sowers JR
    Hypertension; 2008 Feb; 51(2):474-80. PubMed ID: 18172055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR-gamma agonist protects podocytes from injury.
    Kanjanabuch T; Ma LJ; Chen J; Pozzi A; Guan Y; Mundel P; Fogo AB
    Kidney Int; 2007 Jun; 71(12):1232-9. PubMed ID: 17457378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats.
    Gianella A; Nobili E; Abbate M; Zoja C; Gelosa P; Mussoni L; Bellosta S; Canavesi M; Rottoli D; Guerrini U; Brioschi M; Banfi C; Tremoli E; Remuzzi G; Sironi L
    Am J Pathol; 2007 Apr; 170(4):1165-77. PubMed ID: 17392157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
    Whaley-Connell A; DeMarco VG; Lastra G; Manrique C; Nistala R; Cooper SA; Westerly B; Hayden MR; Wiedmeyer C; Wei Y; Sowers JR
    Am J Nephrol; 2008; 28(1):67-75. PubMed ID: 17914247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IP
    Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
    BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells.
    Zeybek ND; Gulcelik NE; Kaymaz FF; Sarisozen C; Vural I; Bodur E; Canpinar H; Usman A; Asan E
    J Endocrinol; 2011 Jul; 210(1):105-15. PubMed ID: 21478229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin beneficially alters the glomerular structure of kidneys from spontaneously hypertensive rats (SHRs).
    de Barros EP; Garcia-Pinto AB; Machado PY; dos Santos Pereira MJ; de Carvalho JJ
    J Mol Histol; 2011 Aug; 42(4):323-31. PubMed ID: 21670990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage.
    Yu L; Liu Y; Wu Y; Liu Q; Feng J; Gu X; Xiong Y; Fan Q; Ye J
    Cell Signal; 2014 Dec; 26(12):2979-91. PubMed ID: 25229402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human proximal tubular epithelium actively secretes but does not retain rosuvastatin.
    Verhulst A; Sayer R; De Broe ME; D'Haese PC; Brown CD
    Mol Pharmacol; 2008 Oct; 74(4):1084-91. PubMed ID: 18612079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
    Shen X; Jiang H; Ying M; Xie Z; Li X; Wang H; Zhao J; Lin C; Wang Y; Feng S; Shen J; Weng C; Lin W; Wang H; Zhou Q; Bi Y; Li M; Wang L; Zhu T; Huang X; Lan HY; Zhou J; Chen J
    Sci Rep; 2016 Sep; 6():32087. PubMed ID: 27580845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.